THE CURRENT MANAGEMENT OF INFECTIOUS DISEASES IN THE LIVER TRANSPLANT RECIPIENT
- 1 August 2000
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 4 (3) , 657-673
- https://doi.org/10.1016/s1089-3261(05)70131-8
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- AMPHOTERICIN B CONCENTRATIONS IN AUTOPSY TISSUES OF ORGAN TRANSPLANT PATIENTS ADMINISTERED AMPHOTERICIN B LIPID COMPLEX INJECTIONTransplantation, 1999
- EFFECTS OF PREEMPTIVE THERAPY IN HEART TRANSPLANT PATIENTS WITH CYTOMEGALOVIRUS - ANTIGENEMIATransplantation, 1999
- Should Prophylaxis for Pneumocystis carinii Pneumonia in Solid Organ Transplant Recipients Ever Be Discontinued?Clinical Infectious Diseases, 1999
- CMV Antigenemia Directed Preemptive Prophylaxis with Oral Ganciclovir for the Prevention of CMV Disease in Liver Transplant Recipients: A Prospective, Randomized, Controlled TrialTransplantation, 1998
- The emergence of vancomycin-resistant enterococci and other resistant organisms in transplantationCurrent Opinion in Organ Transplantation, 1998
- Selection ofCandida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Aspergillus INFECTION IN SINGLE AND DOUBLE LUNG TRANSPLANT RECIPIENTSTransplantation, 1996
- Prevention of cytomegalovirus disease in transplant recipientsThe Lancet, 1995
- Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trialHepatology, 1995
- Invasive Aspergillosis in Liver Transplant Recipients: Association with Candidemia and Consumption Coagulopathy and Failure of Prophylaxis with Low-Dose Amphotericin BClinical Infectious Diseases, 1993